AquaBounty Technologies

AquaBounty Technologies
A biotechnology company focused on genetically engineered salmon for sustainable aquaculture.
About
What does AquaBounty Technologies do?
AquaBounty Technologies is a pioneer in aquaculture, utilizing innovative land-based farming technology and advanced genetics to grow seafood more efficiently and sustainably. The company is dedicated to environmentally responsible, science-based fish farming to improve human health, positively impact climate change, conserve natural resources, and protect marine ecosystems. They serve investors and stakeholders interested in their advancements in aquaculture.
What is AquaBounty Technologies's revenue?
StartupHub estimates AquaBounty Technologies's annual revenue at $878K (range $256K to $3.1M, 33% confidence), based on comparable companies in the sector.
What is AquaBounty Technologies's valuation?
StartupHub estimates AquaBounty Technologies's effective valuation at $16.2M (range $8.4M to $26.3M, 56% confidence), based on comparable companies in the sector.
How much funding has AquaBounty Technologies raised?
AquaBounty Technologies has raised a total of $11M in funding. The most recent round on record is Debt Exchange.
Where is AquaBounty Technologies headquartered?
AquaBounty Technologies is headquartered in Harvard, United States.
When was AquaBounty Technologies founded?
AquaBounty Technologies was founded in 1991.
What industry does AquaBounty Technologies operate in?
AquaBounty Technologies operates in Biotechnology, Aquaculture, Genetically Modified Organisms, Sustainable Seafood, Land-based Aquaculture, Recirculating Aquaculture Systems (RAS).
What is AquaBounty Technologies's current status?
AquaBounty Technologies's current operating status is: Inactive.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.